Aristeia Capital’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Aristeia Capital’s Portfolio ROIVW Stock Details ROIVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-139,754	Closed	-$347K	–	282
2023 Q2	$347K	Sell	139,754 -637,473	-82%	-$1.25M	0.01%	123
2023 Q1	$1.15M	Sell	777,227 -448,845	-37%	-$834K	0.03%	200
2022 Q4	$2.35M	Sell	1,226,072 -17,534	-1%	-$19.2K	0.05%	288
2022 Q3	$491K	Sell	1,243,606 -28,431	-2%	-$15.1K	0.01%	416
2022 Q2	$789K	Sell	1,272,037 -45,647	-3%	-$23.9K	0.01%	378
2022 Q1	$1.23M	Sell	1,317,684 -92,796	-7%	-$118K	0.02%	374
2021 Q4	$2.89M	Buy	+1,410,480	New	+$2.15M	0.05%	346

Aristeia Capital's ROIVW Position: Q3 2023 in Review

Aristeia Capital sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2023, closing a stake of 139,754 shares — an estimated $347K sold.

Aristeia Capital first reported a position in ROIVW in Q4 2021 and held it in 7 quarters. The position peaked at $2.89M in Q4 2021. 0 funds tracked by Wall St. Rank hold ROIVW as of Q3 2023.

Aristeia Capital reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2023 after selling out during the quarter.
Aristeia Capital sold 139,754 Roivant Sciences Ltd. Warrant shares in Q3 2023, an estimated $347K.
Aristeia Capital first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 7 quarters.
Aristeia Capital's Roivant Sciences Ltd. Warrant position peaked at $2.89M in Q4 2021.
0 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2023.

Based on Aristeia Capital's 13F filing for Q3 2023, filed 14 Nov 2023.